Alliancebernstein L.P. Cue Biopharma, Inc. Transaction History

Alliancebernstein L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.49 - $5.92 $83,415 - $198,320	-33,500 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$4.41 - $12.28 $441 - $1,228	100 Added 0.3%	33,500 $163,000
Q2 2021 Jul 30, 2021	BUY	$10.9 - $14.53 $52,320 - $69,744	4,800 Added 16.78%	33,400 $389,000
Q1 2021 May 06, 2021	SELL	$11.2 - $16.09 $36,960 - $53,097	-3,300 Reduced 10.34%	28,600 $349,000
Q3 2020 Nov 12, 2020	SELL	$15.05 - $23.54 $55,685 - $87,098	-3,700 Reduced 10.39%	31,900 $480,000
Q2 2020 Aug 13, 2020	BUY	$12.7 - $30.73 $284,480 - $688,352	22,400 Added 169.7%	35,600 $873,000
Q1 2020 May 14, 2020	BUY	$9.85 - $22.27 $130,020 - $293,964	13,200 New	13,200 $187,000

11.9M

22K

1.2K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $36.1M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.